Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insomnia01:27

Insomnia

81
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
81
Management of Insomnia01:19

Management of Insomnia

235
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
235
Cognitive Therapy01:25

Cognitive Therapy

147
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
147
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

232
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
232
Rational Emotive Behavior Therapy01:24

Rational Emotive Behavior Therapy

45
Cognitive-behavioral therapies (CBTs) are grounded in the belief that our thoughts profoundly influence our emotions and actions. Advocates of CBT emphasize three core assumptions: first, that cognitions are identifiable and measurable; second, that they are central to psychological functioning; and third, that irrational or maladaptive beliefs can be replaced with rational and adaptive ones. This transformative approach to therapy has paved the way for specific models such as Albert...
45
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

159
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
159

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Essential Information About Chronobiology and Chronotherapy for the Optimal Care of People With Bipolar Disorders: An Expert Consensus.

Bipolar disorders·2026
Same author

Nightmare-Focused Interventions and Suicide Prevention: Clarifying the Role of Imagery Rehearsal Therapy and Prazosin.

Sleep·2026
Same author

Nightmares Matter: Rethinking Suicide Risk Assessment and Intervention in Depression.

Sleep·2026
Same author

Evaluation of a Contactless Sleep Monitoring Device for Sleep Stage Detection at Home in a Healthy Population: Prospective Study in Free-Living Conditions.

JMIR human factors·2026
Same author

Digital Cognitive Behavioural Therapy for Insomnia Delivered Within a Crenotherapy Setting: Results from a Multicentre Proof-of-Concept Randomised Controlled Trial.

Journal of clinical medicine·2026
Same author

Therapeutic prospects of bright light therapy in addictive disorders: a scoping review.

Journal of neural transmission (Vienna, Austria : 1996)·2026

Related Experiment Video

Updated: Jun 14, 2025

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

627

Innovative Digital Cognitive Behavioral Treatment for Insomnia Disorder in Adults (dCBT-i): Framework Development.

Emilie Stern1,2, Severine Brune3, Stéphane Mouchabac4,5

  • 1Centre ChronoS, GHU Paris psychiatrie & neurosciences, Paris, France.

JMIR Human Factors
|May 27, 2025
PubMed
Summary

A new digital cognitive behavioral therapy for insomnia (dCBT-i) program was developed to improve accessibility. This evidence-based digital treatment offers personalized care and scalable solutions for insomnia disorder.

Keywords:
CBT-idigital programinsomniaintegrative therapiesnonpharmacological intervention

More Related Videos

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
05:59

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

2.3K
A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
06:23

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice

Published on: September 22, 2020

5.3K

Related Experiment Videos

Last Updated: Jun 14, 2025

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

627
Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
05:59

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

2.3K
A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
06:23

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice

Published on: September 22, 2020

5.3K

Area of Science:

  • Digital Health
  • Behavioral Science
  • Sleep Medicine

Background:

  • Chronic insomnia affects up to 15% of the population, posing a significant health challenge.
  • Cognitive Behavioral Therapy for Insomnia (CBT-i) is the first-line treatment but faces accessibility issues.
  • Digitalization offers a promising avenue to enhance healthcare accessibility and equity.

Purpose of the Study:

  • To develop an evidence-based digital Cognitive Behavioral Therapy for Insomnia (dCBT-i) program.
  • To ensure the program is suitable for integration into healthcare systems.
  • To establish the first prescribed digital therapeutic for insomnia in France.

Main Methods:

  • The program was built upon validated CBT-i principles and the latest scientific research.
  • It incorporates a robust, multicomponent therapeutic approach.
  • Features include standardized initial assessment and intelligent daily adaptation for personalized treatment and digital phenotyping.

Main Results:

  • An innovative digital solution merging scientific rigor with practical application was created.
  • The program features a standardized initial evaluation.
  • Dynamic personalization is achieved through intelligent algorithms adapting therapy to individual patient needs and progress.

Conclusions:

  • The developed dCBT-i program is a significant advancement in digital healthcare.
  • It offers a scalable solution to overcome traditional CBT-i accessibility barriers.
  • Further clinical studies are planned to evaluate effectiveness and optimize implementation.